Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1472 results about "Pathogenesis" patented technology

The pathogenesis of a disease is the biological mechanism (or mechanisms) progress of disease showing its morphological features or that leads to the diseased state. The term can also describe the origin and development of the disease, and whether it is acute, chronic, or recurrent. The word comes from the Greek πάθος pathos ("suffering", "disease") and γένεσις genesis ("creation").

AI-based traditional Chinese medicine dialectical auxiliary diagnosis method and system and medium thereof

The invention discloses an AI-based traditional Chinese medicine dialectical auxiliary diagnosis method and system and a medium thereof, and relates to the technical field of intelligent auxiliary diagnosis, and the method comprises the steps: collecting physiological monitoring data, tongue condition data and pulse condition signals of a patient, obtaining patient symptom information, mapping the patient symptom information to a preset traditional Chinese medicine pathogenesis classification model, and generating an initial symptom feature vector; calling a knowledge base containing traditional Chinese medicine prescription rules and compatibility medication taboo, performing data space-time alignment processing and dynamic combination calculation on the initial symptom feature vector, and generating a personalized candidate prescription set conforming to the traditional Chinese medicine compatibility taboo; according to dynamic combination calculation, a solution algorithm based on a constraint satisfaction problem is adopted, and multi-dimensional association rule matching is carried out in combination with the mapping relation between syndromes and modern medical symptoms; and outputting a prescription medication recommendation scheme containing traditional Chinese medicine compatibility, dosage and decoction methods based on the candidate prescription set. The method supports the formulation of an accurate personalized diagnosis and treatment scheme, and meets the requirements of high-quality traditional Chinese medicine personalized auxiliary diagnosis and treatment.
Owner:GUANGZHOU JUHAI SOFTWARE TECH CO LTD

Cerebral stroke prediction method and device based on cerebrovascular image representation group, medium and product

The invention discloses a cerebral apoplexy prediction method and device based on a cerebrovascular image representation group, a medium and a product, and relates to the field of image processing, and the method comprises the steps: constructing a clinical database; according to the multi-modal image feature group data, the clinical feature data and the clinical cause typing of the patient, constructing a clinical cause typing prediction model; according to TOF-MRA, a cerebrovascular tissue segmentation model and voxel-based morphological analysis are adopted to determine cerebrovascular image features, and positioning diagnosis of a responsible blood vessel area is carried out according to the cerebrovascular image features; according to the cerebrovascular image features in the TOF-MRA, the SWI, the T1WI, the T2-FLAIR and the corresponding clinical feature data, a cerebral apoplexy recurrence risk prediction model is constructed; according to the application, the pathogenesis classification of the acute cerebral apoplexy patient can be quickly and accurately realized in a clinical scene, the responsible blood vessel can be accurately identified, and the recurrence risk prediction can be realized in the early stage of the disease.
Owner:BEIJING TIANTAN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV

Multi-center child pulmonary embolism online data platform system

The invention discloses a multi-center child pulmonary embolism online data platform system, and belongs to the technical field of data processing. A data collection step: collecting electronic medical records, image data, laboratory results and treatment scheme multi-source data uploaded by each center, and unifying data formats and standardizing processing flows; a machine learning and artificial intelligence algorithm step: carrying out deep analysis on mass data, identifying risk factors, pathogenesis and treatment response modes of children pulmonary embolism, and supporting personalized medical decisions; a dynamic risk assessment tool step: developing a dynamic risk assessment tool according to the latest research results and clinical guidelines, and providing real-time treatment suggestions and prognosis assessment for doctors; a data security and privacy protection step: adopting a data encryption step and an anonymization step to ensure the security and privacy protection of patient information; and a multi-center cooperative network step: establishing a children pulmonary embolism research and treatment cooperative network nationwide through a data sharing and remote cooperation mechanism.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL

Method for constructing prediction model of pan-apoptosis related biomarkers of asthma based on convolutional neural network algorithm and application

The invention discloses a method for constructing a prediction model of pan-apoptosis related biomarkers of asthma based on a convolutional neural network algorithm and application, and the method comprises the steps: firstly obtaining related data from a database, and determining characteristic pan-apoptosis related genes PDGs in asthma through an SVM support vector machine, LASSO regression analysis and RF random forest regression; the method comprises the following steps: establishing an lncRNA-miRNA-mRNA network by using interaction STRING and Cytoscape software, constructing a prediction model of the pan-apoptosis related biomarkers of asthma through a convolutional neural network, and analyzing the diagnosis accuracy of potential target genes through an ROC curve. 10 characteristic PDGs playing an important role in asthma are finally obtained, the difference of the genes between a normal group and an asthma group is proved, and the enrichment pathway and immune cell infiltration of the genes have a certain relation with the occurrence and development of asthma, so that a prediction model of the pan-apoptosis related biomarkers of asthma is constructed, and the prediction model is used for predicting the pan-apoptosis related biomarkers of asthma. And a new research direction is provided for studying the pathogenesis and treatment of asthma.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIV +1

Phytophthora plant pathogenic oomycete arginine methyltransferase protein as well as coding gene and application thereof

ActiveCN119242606Areduce outputReduced growth rateBiocideFungiBiotechnologySporeling
The invention discloses arginine methyltransferase protein from phytophthora plant pathogenic oomycetes as well as a coding gene and application thereof. The arginine methyltransferase protein provided by the invention is as shown in sequences 6-8; the coding gene is shown in sequences 1-3. Experiments prove that the protein disclosed by the invention plays an important role in growth, development and pathopoiesis processes of typical phytophthora plant pathogen oomycete phytophthora capsici, and after the protein is deleted or the expression level is reduced, the growth rate of phytophthora capsici hyphae is reduced, the sporangium yield is reduced, the number of zoospore is reduced, the pathogenicity is reduced and the like. Corresponding arginine methyltransferase inhibitors have different degrees of activity on typical plant pathogenic oomycetes such as phytophthora capsici, phytophthora sojae and phytophthora infestans. The gene provided by the invention has great application potential in the aspect of preventing and controlling the crop epidemic diseases caused by phytophthora plant pathogenic oomycetes, and a novel bactericide developed based on the protein as an action target has important practical significance in controlling the occurrence and prevalence of the crop epidemic diseases caused by phytophthora.
Owner:CHINA AGRI UNIV

Method for constructing Ddx58-R109C point mutation mouse model and application of Ddx58-R109C point mutation mouse model

The invention discloses a method for constructing a Ddx58-R109C point mutation mouse model by using a CRISPR / Cas9 gene editing technology and an application of the Ddx58-R109C point mutation mouse model. The method comprises the following steps: (1) target construction: searching a CDS region of a Ddx58 gene, determining an exon part, and determining a gene mutation site; (2) obtaining a fertilized egg, and injecting Cas9mRNA, gRNA and donor oligo into the fertilized egg of the C57BL / 6J mouse together in vitro through a microinjection technology to obtain an F0-generation hybrid mouse; (3) mating the F0-generation hybrid mouse with the wild type mouse to obtain an F1-generation mouse; (4) the F1-generation heterozygous mice which are identified to be positive are subjected to mating, and homozygous Ddx58-R109C mutant type and wild type mice can be obtained by breeding obtained offspring; (5) phenotypic analysis shows that Ddx58-R109C point mutation mice can have pathological changes of systemic lupus erythematosus and lupus nephritis; the invention can provide an effective research approach and method for researchers to deeply explore the action mechanism of Ddx58-R109C mutation in diseases, and has important significance for explaining the pathogenesis of systemic lupus erythematosus and researching and developing targeted therapeutic drugs.
Owner:NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A

Construction method of mouse hyperuricemia model

The invention discloses a construction method of a mouse hyperuricemia model, which comprises the following steps: by taking a yeast extract, hypoxanthine and oteracil potassium as molding agents, carrying out a molding test on a test mouse for 14-21 days to obtain the hyperuricemia mouse model, during the modeling test, the blood uric acid content of the test mouse is detected every week. Yeast extract and hypoxanthine in which uric acid precursor substances are increased for a long time are adopted, meanwhile, a uricase inhibitor oteracil potassium is used in a combined mode, a model similar to the pathogenesis of human hyperuricemia is prepared through the synergistic effect of the three model making agents, and the model is used for treating hyperuricemia of a human body. The hyperuricemia renal injury mouse model which is reasonable and stable in effect and conforms to clinical characteristics can be successfully constructed after 14-21 days.
Owner:INST OF CHINESE MATERIA MEDICA HUBEI ACAD OF AGRI SCI +1

Application of Ackermania muciniphila or extracellular vesicles thereof in preparation of medicine for alleviating alcoholic ischemic necrosis of femoral head

The invention belongs to the field of biological medicines, and discloses an application of Akkermansia muciniphila or an extracellular vesicle of the Akkermansia muciniphila in preparation of a medicine for alleviating the ischemic necrosis of the alcoholic femoral head. Based on the pathogenesis characteristics of the AIONFH, the Akk bacteria and the extracellular vesicles thereof are used for treating the AIONFH for the first time, the molecular mechanism of the Akk bacteria and the extracellular vesicles thereof for regulating and controlling the intestinal tract-skeleton axis function, inhibiting bone cell apoptosis and improving the bone trabecula microstructure is deeply researched, the anti-pressure ability of bone tissue is improved, and the research blank in the field is filled. Compared with a traditional treatment method, the osteonecrosis pathological change is improved through a single way, and a novel multi-target treatment strategy is provided from multiple aspects of regulating inflammatory response, recovering bone metabolism balance, promoting intraosseous blood supply and the like.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV

Traditional Chinese medicine composition for treating autism spectrum disorder and application thereof

The invention discloses a traditional Chinese medicine composition for treating autism spectrum disorder and application thereof, and belongs to the technical field of traditional Chinese medicine compositions. The traditional Chinese medicine composition is prepared from the following components in parts by mass: 4 to 10 parts of cortex cinnamomi, 4 to 10 parts of radix morindae officinalis, 4 to 10 parts of radix polygalae, 4 to 10 parts of rhizoma acori graminei, 5 to 10 parts of radix rehmanniae praeparata, 4 to 10 parts of radix angelicae sinensis, 8 to 20 parts of tortoise shell and 5 to 10 parts of herba dendrobii. From the perspective of overall compatibility, the cinnamon and the morinda officinalis in the composition can warm and tonify kidney yang, the prepared rehmannia root, the tortoise shell and the dendrobe nourish yin and tonify kidney to prevent excessive warm tonification, the angelica sinensis can enrich blood and activate blood and give consideration to spleen and stomach, the polygala tenuifolia can traffic heart and kidney, soothe the nerves and promote intelligence, and the rhizoma acori graminei can reduce phlegm, induce resuscitation and induce resuscitation. The medicines are matched with one another to jointly achieve the effects of tonifying spleen and kidney, replenishing essence and benefiting marrow, and inducing resuscitation and promoting intelligence, and the symptoms of autism are comprehensively improved from the fundamental pathogenesis of spleen-kidney deficiency and by considering pathological changes such as phlegm clogging the heart and the like.
Owner:BEIJING UNIV OF CHINESE MEDICINE THIRD AFFILIATED HOSPITAL

Disease remote diagnosis system based on artificial intelligence driving

The invention relates to the technical field of artificial intelligence medical diagnosis, and discloses a remote disease diagnosis system based on artificial intelligence driving. The system comprises five functional modules, a real-time medical data acquisition module acquires multi-modal physiological data of a patient from a remote terminal in real time, and the multi-modal physiological data comprises vital sign time sequence data, medical image data and symptom description text data; the cross-modal correlation analysis module carries out feature fusion on the data, extracts a correlation mode between modals and generates an abnormal feature data set with a weight mark; establishing a dynamic diagnosis baseline by the dynamic diagnosis baseline model, and adapting to individual physiological feature changes by updating parameters; the abnormal behavior detection module is used for comparing the real-time data with a baseline, identifying abnormal indexes and generating a marking result; the deep pathogenesis tracing module analyzes a potential disease mode and traces a pathogenesis path in combination with a patient's historical medical record. The system can optimize the remote diagnosis effect and assist clinical diagnosis and treatment.
Owner:FUJIAN PROVINCIAL HOSPITAL

SLC44A1 gene and / or SLC44A5 gene knockout animal model as well as construction method and application thereof

The invention belongs to the technical field of biology, and particularly relates to an SLC44A1 gene and / or SLC44A5 gene knockout animal model as well as a construction method and application thereof. The construction method of the animal model comprises the following steps: deleting exon regions from the fourth exon region to the thirteenth exon region of the SLC44A1 gene and / or the second exon region of the SLC44A5 gene in mouse brain oligodendroglia cells in a high-efficiency manner by utilizing gene editing and a Cre-loxP recombinase system, so as to realize the knockout of a target gene. The animal model constructed by the invention can be used for researching the regulation mechanism of the choline transporters (SLC44A1 and SLC44A5) on myelin sheath formation, deeply knowing the biological functions of the choline transporters (SLC44A1 and SLC44A5), simulating the occurrence and development processes of human related diseases, revealing the pathogenesis of the related diseases, providing a new thought for prevention and treatment of brain myelin sheath dysplasia, and providing a new foundation for the prevention and treatment of brain myelin sheath dysplasia. And an effective drug or a treatment mode aiming at the disease is screened by utilizing a gene knockout animal model, so that a new choice is provided for clinical treatment of the disease.
Owner:ARMY MEDICAL UNIV

Intestinal bacteria and serum metabolites capable of serving as type 2 diabetes biomarkers and application of intestinal bacteria and serum metabolites

The invention discloses intestinal bacteria and serum metabolites which can be used as biomarkers of type 2 diabetes mellitus (prediabetes mellitus (PDM), new diagnosis diabetes mellitus (NDDM) and diabetes mellitus (P2DM) after medication) in different disease stages, and application of the intestinal bacteria and the serum metabolites. Aiming at type 2 diabetes mellitus, predictive markers including staphylococcus aureus, escherichia coli, klebsiella pneumoniae, branched chain amino acids (leucine, valine and isoleucine) and the like, especially staphylococcus aureus of which the genome contains acetolactate synthase (ALS), are efficiently screened out. The type 2 diabetes mellitus marker disclosed by the invention can be used for early warning the illness risk of type 2 diabetes mellitus and guiding the adjustment of an intestinal microbial environment; the method can be used for indicating the correlation between the intestinal microbial environment and the type 2 diabetes mellitus and is used for assisting diagnosis; and drug action target research, accurate medication, pathogenesis research and the like are realized.
Owner:GUANGDONG GENERAL HOSPITAL

Stroke polygenic risk score and pathogenesis risk evaluation device and application thereof

Provided are a stroke polygenic risk score (PRS) and a pathogenesis risk evaluation device and an application thereof. Specifically, provided is an application of a reagent, which is used for detecting individual information, in preparation of a detection device for evaluating a pathogenesis risk of stroke, wherein the individual information comprises 280 Stroke-related single nucleotide polymorphism sites. The individual information preferably further comprises one or more of CAD, SBP, WC, T2D, TC, PP, and AF-related single nucleotide polymorphism sites. The PRS and a traditional risk factor are further integrated, so that re-stratification of the pathogenesis risk of stroke can be achieved, and important significance for primary prevention of stroke is achieved.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

Diabetes intestinal microbial marker, application thereof and method for constructing diabetes detection model

The invention provides a diabetes mellitus intestinal microbial marker, application thereof and a method for constructing a diabetes mellitus detection model, and belongs to the technical field of medicine and biomedicine. The method comprises the following steps: extracting biomarkers related to the pathogenesis and progress of diabetes from metagenome data, constructing a random forest model by using a random forest algorithm, and training and testing the constructed random forest model by using a training set and a test set to obtain a diabetes detection model. According to the diabetes detection model, differential bacteria of a diabetic patient and a healthy control can be identified more accurately, so that the accuracy of early auxiliary diagnosis of diabetes is improved, and the treatment effect is improved. The invention provides specific intestinal microbial markers for identifying diabetes mellitus, which reveal the change in the metabolic pathway of the host-microorganism associated with diabetes mellitus, contributing to the discovery of new biomarkers or therapeutic targets for diabetes mellitus.
Owner:QIANJI (XIAN) BIOMEDICAL TECHNOLOGY CO LTD

AI syndrome differentiation and treatment model system suitable for multi-dimensional difference environment

The invention discloses an AI syndrome differentiation and treatment model system suitable for a multi-dimensional difference environment, which comprises a data integration layer and a three-cause characteristic processing and dynamic dialectical model, and is characterized in that the data integration layer comprises outpatient service data, hospitalization data, follow-up visit data, physical characteristics, pathogenesis solar terms / five-transportation six-qi and regional medicinal material relationships; the three-factor feature processing comprises human-factor feature processing, time-factor feature processing and place-factor feature processing; the dynamic dialectical model comprises multi-modal data fusion, three-factor weight dynamic allocation and curative effect correction syndrome reasoning. The syndrome differentiation accuracy of chronic epigastric pain patients reaches 89.2%, the clinical curative effect and acceptability of a treatment scheme are improved, the average iteration period of the model is shortened to 72 h through a feedback closed-loop system, the method deeply conforms to Chinese geographical population characteristics, and the method has the advantages of being high in adaptability and good in application prospect through an environment perception-physique evaluation-dynamic syndrome differentiation three-level linkage mechanism. Precise diagnosis and treatment of one person with one prescription at once is achieved, and core technical support is provided for modernization of traditional Chinese medicine.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Method for detecting EBV latent infection of epithelial cells and B cells in thymus and salivary gland tissue microenvironment

The invention relates to a detection kit and a detection method for EBV latent infection of epithelial cells and B cells in a thymus and salivary gland tissue microenvironment, and the detection method comprises the following steps: dyeing thymus and salivary gland tissues by coupling quantum dots and a specific antibody; the conjugate of the quantum dots and the specific antibody is combined with a specific antigen of a tissue sample to realize marking of EBV latent infection epithelial cells and B cells by the quantum dots. According to the invention, the existing multicolor immunofluorescence technology is improved, the specific antibody and the quantum dot are coupled and purified and then are directly combined with the antigen on the tissue slice to realize direct marking of the quantum dot coupled antibody on the tissue sample, so that EBV latent infection cells in the thymus and salivary gland tissue microenvironment are positioned and quantified; the virus infection condition of the patient is evaluated from the pathogenesis level, the disadvantage that the previous evaluation means are limited is overcome, and the method has good sensitivity and accuracy.
Owner:TIANJIN MEDICAL UNIV GENERAL HOSPITAL AIRPORT HOSPITAL

Application of WNT7B in construction of myopia animal model

The invention provides an application of WNT7B in construction of a myopia animal model. Homologous genes wnt7ba and wnt7bb of the WNT7B in the zebra fish are knocked out or knocked down by applying a CRISPR / Cas9 gene editing technology, an animal model of which the eye axis length is remarkably increased, the eyeball movement frequency is remarkably reduced and the light response is reduced is obtained, and the result shows that the WNT7B is related to the high myopia. The model provides a favorable tool for pathogenesis and drug screening of high myopia, and has a good application prospect.
Owner:THE EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY +1

Organ chip unit, chip and research method

PendingCN119823867ATissue/virus culture apparatusCartilage cellsSynovial Cell
The invention provides an organ chip unit for simulating the pathogenesis of rheumatoid arthritis, and belongs to the technical field of cell culture. The chip comprises a top-layer chip, a bottom-layer chip and a middle microporous membrane, the top-layer chip and the bottom-layer chip are separated by the middle microporous membrane, and the middle microporous membrane is used for enabling cells in a cell culture space of the top-layer chip and cells in a cell culture space of the bottom-layer chip not to be in direct contact, but interaction of signal molecules and substance exchange can be carried out; synovial cells and cartilage cells are injected into the bottom-layer chip or the top-layer chip to be cultured. According to the invention, multi-cell three-dimensional co-culture can be realized. Through the additional stress stimulation co-culture part, the influence of pressure or tension on the cell environment can be judged, and the actual condition that rheumatoid arthritis joints receive pressure or tension for a long time can be simulated. The synovial cells and the cartilage cells are used, so that the structure of the inflammation joint in a living body can be truly reflected, and the interaction among various cell tissues can be reflected.
Owner:EAST CHINA UNIV OF SCI & TECH

Double-antibody sandwich ELISA kit for detecting human beta-NGF content

The invention belongs to the field of immunological detection, and provides a double-antibody sandwich ELISA kit for detecting the content of human beta-NGF. The enzyme-linked immunosorbent assay kit constructed by the invention is based on a double-antibody sandwich method, and is combined with a biotin-streptavidin signal amplification system and an enzyme developing amplification system, so that the detection sensitivity and specificity are greatly improved, and low-content samples can be accurately and quickly detected. The kit shows excellent stability and specificity and can be used for quantitatively detecting the content of beta-NGF in samples such as human serum, cell supernatant or tissue homogenate, so that an objective detection basis is provided for diagnosis, curative effect evaluation and pathogenesis research of related diseases.
Owner:BEIJING SOLARBIO TECH CO LTD +1

Method for constructing chronic unpredictable negative stress model, chronic unpredictable negative stress model and application of chronic unpredictable negative stress model in mental disease research

The invention provides a method for constructing a chronic unpredictable negative stress model, the chronic unpredictable negative stress model and application of the chronic unpredictable negative stress model in mental disease research, and belongs to the field of brain organ in-vitro model construction. Through dual verification of a microelectrode array and single cell sequencing, an in-vitro brain organ model capable of simulating chronic unpredictable negative stress core characteristics is successfully constructed, and a potential neural network function reconstruction mechanism and a cell molecule basis of the in-vitro brain organ model are disclosed. The comprehensive research normal form breaks through the limitation of a traditional single technology platform, and an accurate and efficient innovative research platform highly related to human is provided for pathogenesis research of mental diseases, especially chronic stress related diseases such as depression and anxiety and development of novel treatment strategies.
Owner:HANGZHOU SEVENTH PEOPLES HOSPITAL

Induced sputum single-cell suspension as well as preparation method and application thereof

The invention relates to an induced sputum single-cell suspension as well as a preparation method and application thereof. The preparation method comprises the following steps: obtaining a filtered sputum suspension to be detected; performing low-temperature centrifugation; centrifuging the sample, and removing supernate; precipitating the cells, adding DPBS which does not contain calcium and magnesium ions, lightly mixing with a transfer pipette, and repeatedly inverting the transfer pipette to enable the cell pellets to suspend again; filtering and collecting filtrate; performing low-temperature centrifugation on the filtrate collected in the previous step, and removing supernate without damaging cell precipitation; adding a proper amount of DPBS free of calcium and magnesium ions into the cell precipitate obtained in the previous step, and gently mixing with a pipette; and adjusting the volume of the suspension to obtain the target cell concentration, thereby obtaining the single-cell suspension. According to the present invention, the induced sputum single cell suspension is prepared, such that a large amount of sputum single cells can be enriched, and the obtained induced sputum single cell suspension can be used for single cell transcriptome sequencing so as to well detect the gene expression condition of the sputum cells, such that the airway inflammation pathogenesis can be easily explored, and the clinical treatment can be easily guided.
Owner:THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (GUANGZHOU RESPIRATORY CENT)

Application of docosapentaenoic acid in preparation of medicine for preventing and / or treating systemic lupus erythematosus

The invention discloses application of docosapentaenoic acid or medicinal salt thereof in preparation of a medicine for preventing and / or treating systemic lupus erythematosus. The invention aims to provide novel application of docosapentaenoic acid in treatment of systemic lupus erythematosus. In view of various immune abnormalities existing in the systemic lupus erythematosus morbidity process, the docosapentaenoic acid has potential application value in the field of systemic lupus erythematosus treatment due to the effects of regulating immune cell functions and improving immune microenvironment.
Owner:THE NAVAL MEDICAL UNIV OF PLA

RSV infection immortalized tree shrew aortic vascular endothelial cell model

The invention discloses an RSV infection immortalized tree shrew aorta vascular endothelial cell model, and particularly relates to a method for separating and culturing primary aorta vascular endothelial cells from tree shrew aorta, further establishing an immortalized tree shrew aorta vascular endothelial cell line, taking the cell line as an RSV virus culture medium, and constructing an RSV infection immortalized tree shrew aorta vascular endothelial cell model. Establishing an RSV infected immortalized tree shrew aortic vascular endothelial cell model, and preparing a high-infection-titer RSV virus; the invention provides key support for preparation and detection of RSV virus and construction of a tree shrew in-vivo infection model, provides a stable virus source for development of comparative medical research or vaccine evaluation, and has far-reaching significance for deep exploration of RSV pathogenic mechanism, drug and vaccine evaluation and the like.
Owner:INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI

Construction method and application of kidney stone induced acute kidney injury mouse model

The invention belongs to the technical field of animal models, and provides a construction method and application of a kidney stone induced acute kidney injury mouse model. The construction method of the kidney stone induced acute kidney injury mouse model comprises the following steps: firstly, fasting and depriving water of a mouse for 12 hours, then injecting 10mg / kg sodium oxalate solution into the body of the mouse in an intraperitoneal injection manner, and meanwhile, replacing drinking water with 3wt% sodium oxalate solution, so that the kidney stone induced acute kidney injury mouse model can be obtained 24 hours later. The sodium oxalate solution is used as the lithigenic agent, the effect is obvious and reliable, the action is strong, the stability and the repeatability are high, the obtained acute kidney injury mouse model is used for subsequent AKI pathogenesis and AKI generation experiment research or drug screening, the observation is obvious, and the method is simple.
Owner:NANTONG UNIV

Monoclonal antibodies that bind specifically to human TRBV9

A monoclonal humanized antibody or antigen-binding fragment thereof that specifically bind to the TRBV9 family of the human T cell receptor. A nucleic acid encoding the antibody or antigen-binding fragment thereof, an expression vector, a method for preparing the antibody, and use of the antibody in treatment of diseases or disorders associated with the human T cell receptor family. The generation of antibodies that can be used for treating, in particular AS, celiac disease and malignant blood diseases, the pathogenesis of which involves the TRBV9 family TCRs.
Owner:JOINT CO BIOCAD

Monoclonal antibodies against the beta chain region of human TRBV9

The invention relates to a monoclonal humanized antibody or antigen-binding fragment thereof that specifically bind to the TRBV9 family of the human T cell receptor. The invention also relates to a nucleic acid encoding said antibody or antigen-binding fragment thereof, an expression vector, a method for preparing said antibody, and use of said antibody in treatment of diseases or disorders associated with the human T cell receptor family. The invention is directed to generation of antibodies that can be used for treating, in particular AS, celiac disease and malignant blood diseases, the pathogenesis of which involves the TRBV9 family TCRs.
Owner:JOINT CO BIOCAD

Traditional Chinese medicine composition for treating sarcopenia

The invention discloses a traditional Chinese medicine composition for treating sarcopenia, the traditional Chinese medicine composition is prepared from six medicines of sugared ginseng, cistanche, rhizoma polygonati, poria cocos, gastrodia elata and bighead atractylodes rhizome through compatibility, the traditional Chinese medicine composition takes spleen strengthening, qi supplementing, kidney tonifying and essence replenishing as the treatment rule, syndrome differentiation treatment is carried out aiming at the spleen and kidney deficiency pathogenesis of sarcopenia, multi-target intervention on sarcopenia is achieved, and the traditional Chinese medicine composition has the advantages that the curative effect is good; the traditional Chinese medicine composition not only can quickly improve muscle strength and endurance functions, but also can continuously promote muscle mass reconstruction, and has dual effects of atrophy resistance and fibrosis resistance, and animal experiment results show that the traditional Chinese medicine composition has a remarkable curative effect on liver and kidney deficiency type sarcopenia.
Owner:HUBEI PROVINCIAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE (AFFILIATED HOSPITAL OF HUBEI UNIV OF TRADITIONAL CHINESE MEDICINE HUBEI INST OF TRADITIONAL CHINESE MEDICINE)

Big data mining system based on traditional Chinese medicine diabetes database

The invention discloses a big data mining system based on a traditional Chinese medicine diabetes database in the technical field of big data, and the system comprises an acquisition unit and a construction unit, and the construction unit is used for obtaining the age, gender, pathogenesis, illness, traditional Chinese medicine diagnosis and traditional Chinese medicine symptom type of a patient according to the features of the patient, and obtaining the drug type according to a prescription; constructing a matrix of different drug types and the age, gender, pathogenesis, disease symptoms, traditional Chinese medicine diagnosis and traditional Chinese medicine symptom types of the patient, thereby constructing the association between the different drug types and the age, gender, pathogenesis, disease symptoms, traditional Chinese medicine diagnosis and traditional Chinese medicine symptom types of the patient, and establishing a special diabetes disease knowledge graph; an input unit; and the mining unit is used for mining required treatment drugs from the special diabetes disease knowledge map according to the age, the gender, the pathogenesis, the diseases, the traditional Chinese medicine diagnosis and the traditional Chinese medicine symptom type so as to solve the problem that in the prior art, the drug combination in the prescription is difficult to flexibly adjust according to the physique and the symptom of the patient, so that the mined prescription is relatively weak in pertinence.
Owner:KUNZHI SHULIAN TECH (NINGBO) CO LTD +1

Traditional Chinese medicine composition for preventing / treating systemic lupus erythematosus and application thereof

The invention discloses a traditional Chinese medicine composition for preventing / treating systemic lupus erythematosus and application thereof.The traditional Chinese medicine composition is reasonably combined according to etiology and pathogenesis of systemic lupus erythematosus, pseudo-ginseng, ginseng, glossy privet fruit and syngnathus serve as monarch drugs, and the traditional Chinese medicine composition has the effects of promoting blood circulation to remove blood stasis, nourishing the liver and tonifying the kidney and directly tonifying yin deficiency of the liver and the kidney; salvia miltiorrhiza, safflower, peach kernel, American ginseng, codonopsis pilosula, prepared rhizome of rehmannia, wolfberry, mulberry and panax japonicus are taken as ministerial drugs and are matched to assist the monarch drugs and clear stasis heat, cornu cervi pantotrichum, herba epimedii, hippocampus, pericarpium citri reticulatae, polygonum multiflorum, angelica sinensis, radix paeoniae alba, rhizoma polygonati and dog kidney are taken as adjuvant and conductant drugs and assist the monarch and ministerial drugs to harmonize yin and yang, all the drugs are matched and have a synergistic effect, and the effects of nourishing kidney and replenishing essence, reinforcing qi and nourishing yin, promoting blood circulation to remove meridian obstruction, warming yang and removing stasis can be achieved. The traditional Chinese medicine can treat both symptoms and root causes, and can effectively treat systemic lupus erythematosus.
Owner:李孝品

Treatment scheme matching method for rehabilitation treatment of chronic obstructive pulmonary disease patient

The invention relates to the technical field of rehabilitation treatment of chronic obstructive pulmonary patients, and discloses a therapeutic scheme matching method for rehabilitation treatment of chronic obstructive pulmonary patients, comprising the following steps: step 1, a data acquisition and integration module which is responsible for collecting multi-dimensional data of patients; according to the treatment scheme matching method for the rehabilitation treatment of the chronic obstructive pulmonary disease patient, unnecessary medical resource waste can be avoided, the patient can be timely and properly treated, the overall utilization efficiency of the medical resources is improved, detailed treatment information and self-management suggestions are provided for the patient, and the patient is prevented from suffering from chronic obstructive pulmonary disease. A patient can better know the illness state and the treatment process of the patient, a personalized treatment scheme is easier to accept and execute by the patient, the treatment compliance of the patient can be improved, a large amount of real-world patient data is accumulated by the system, rich materials are provided for medical research, and through deep mining and analysis of the data, the treatment compliance of the patient can be improved. Pathogenesis, treatment effect influence factors and the like can be further explored.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE